Trial intelligence / Profile preview

Nalbuphine versus fentanyl for gastrointestinal function in postoperative ICU patients

ChiCTR1900025096Phase 4Recruiting

Sponsor
Xijing Hospital
Start
Jul 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of nalbuphine and fentanyl in postoperative pain (2 arms), sponsored by Xijing Hospital. Primary endpoint: First defecation or exhaust time. Started Jul 2019; status: recruiting.

02

Drugs

nalbuphinefentanyl
03

Conditions

postoperative pain

Beyond the preview

Go deeper on ChiCTR1900025096.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900025096.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call